A key trend shaping the Automated Analyzers Market involves the Innovative Advancements In Automated Clinical Chemistry Enhanced Market Growth
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Automated Analyzers Market During The Forecast Period 2026–2030?
The market size for automated analyzers has experienced robust expansion in recent years. This market is projected to expand from $5.39 billion in 2025 to $5.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this growth was driven by factors such as the prevalence of manual and semi-automated testing methods, constraints in laboratory workforce efficiency, a rise in clinical testing volumes, the proliferation of diagnostic laboratories, and a dependence on conventional analyzers.
The automated analyzers market is anticipated to experience significant expansion over the coming years. This market is projected to reach $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the forecast period include advancements in fully automated analyzers, the integration of AI and big data analytics, increasing demand for rapid diagnostics, the expansion of genomics and proteomics research, and the widespread adoption of point-of-care testing solutions. Key trends expected over the same period encompass the growing adoption of automated laboratory systems, an escalating demand for high-throughput sample processing, the incorporation of multi-functional analyzers in laboratories, expansion in clinical diagnostics and research applications, and improved accuracy and standardization in analytical testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp
Which Major Factors Are Driving The Expansion Of The Automated Analyzers Market?
The increasing incidence of chronic illnesses is anticipated to drive the expansion of the automated analyzers market in the future. This surge in chronic disease cases stems from an aging global populace, detrimental lifestyle choices, and heightened urbanization. Automated analyzers play a crucial role in managing chronic diseases by facilitating precise and effective diagnostic tests, which aids in the prompt identification, continuous observation, and therapeutic intervention for ailments such as diabetes, cardiovascular diseases, and kidney disorders. For example, in June 2023, a report issued by Kidney Research UK, a non-profit organization based in the UK, indicated that around 7.2 million individuals in the UK are affected by chronic kidney disease, accounting for more than 10% of the population. Among these individuals, 3.25 million suffer from advanced forms of the disease, whereas another 3.9 million are in its initial phases. Projections suggest that by 2033, the total number of people afflicted with chronic kidney disease will increase to 7.61 million. Consequently, the growing occurrence of chronic illnesses is fostering expansion within the automated analyzers market.
What Market Segments Are Evaluated Within The Automated Analyzers Market?
The automated analyzers market covered in this report is segmented –
1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types
2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types
3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems
2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers
3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers
4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers
What Industry Trends Are Redefining The Automated Analyzers Market?
Major companies operating in the automated analyzers market are focusing on developing advanced solutions, including automated clinical chemistry analyzers, to enhance efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers are sophisticated instruments used in laboratories to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, thereby boosting the efficiency and accuracy of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, introduced the DxC 500 AU Chemistry Analyzer, which signifies a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly improve the capabilities of satellite and independent community hospital labs. It incorporates sophisticated automation, streamlined workflows, and standardized reagents to enhance testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.
Who Are The Top Market Participants Influencing The Automated Analyzers Market?
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
Read the full automated analyzers market report here:
https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report
Which Region Currently Holds The Largest Share Of The Automated Analyzers Market?
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Automated Analyzers Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp
Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company
Hematology Analyzers And Reagents Market Report 2026
Blood Gas And Electrolyte Analyzers Market Report 2026
Veterinary Hematology Analyzers Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model